genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Artificial Intelligence
From Model to Molecule: NVIDIA Doubles Down on AI Drug Discovery
AgBio
Let There Be Light: GreenLight Strives for Global RNA Equity to…
Coronavirus
Icosavax: Giving VLPs the VIP Treatment
CRISPR
Inscripta Eyes Broader Genome Editing Reach with $150M Series E
Drug Discovery
You Can See Manhattan from Your Lab: $3B “Cove” Campus Announced…
News
Alzheimers
Mouse Model of Alzheimer’s Reveals Some Plaques May Defend and Not…
Biomarker Discovery
Genetic Markers Discovered that Open Door to Potential New Lung Cancer…
CRISPR-Cas9
Parallel Genome Editing in Microscopic Worms Maps Regulatory Genomic Elements to…
Drug Discovery
Heart Drug Reverses Obesity and Related Metabolic Disorders in Mice
Antibodies
Machine Learning Helps Optimize Therapeutic Antibodies
Insights
All
Trends for 2020
Trends for 2021
Antisense
n-Lorem Makes Ultrarare Disease Treatment Personal
Bioprocessing
Getting the Most Out of Your Intensified Bioprocess
Antibodies
Whence the Facility Expansions?
Bioprocessing
CDMOs Embrace Innovative Tech to Create “Digital Threads”
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
A-Lists
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Authors
Posts by Gail Dutton
Gail Dutton
281 POSTS
0 COMMENTS
On Your Radar
Powering Perfusion at the Microscale
On Your Radar
In Workflows, Let the Perfect Be the Ally of the Good
On Your Radar
Disease Cancelling Technology Emulates Sound Cancelling Technology to Mute Cancer
On Your Radar
Technological Threefold Way Leads to Biological Wisdom
On Your Radar
Immune Profiling System Redirected in Light of COVID-19
On Your Radar
Catch RNA Splicing Errors to Envision Novel Correctives
Point of View
Going “Cell Free” Can Put a Rush on COVID-19 Antibody Therapies
On Your Radar
Empowering Labs with Multiplatform Testing Options
On Your Radar
Bacterial Platforms Can Rival Mammalian Platforms
On Your Radar
Imaging Module Gives 2D Microscopes 3D Vision
1
2
3
...
29
Page 1 of 29
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
